Table of Content

1. Overview
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency And Limitation
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research / Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions For the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Trends
4.3.1. Industry Trends
4.3.1.1. Increasing Partnerships and Collaborations among NGS Instrument Manufacturers to Expand and Improve Product Offerings
4.3.2. Technology Trends
4.3.2.1. Development of Portable Sequencing Technologies
4.3.2.2. Increasing Demand for NGS Automation
4.4. Case Studies
4.4.1. Clear Labs, Inc. (U.S.) Offers Google Cloud Services-based NGS Platform for Food Safety Testing
4.4.2. Pairend Biotechnology (Turkey) Offers NGS Cloud, an Artificial Intelligence-Supported Genetic Data Analysis Platform
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Buyers
4.5.2. Bargaining Power of Suppliers
4.5.3. Threat of Substitutes
4.5.4. Threat of New Entrants
4.5.5. Degree of Competition
4.6. Pricing Analysis

5. Next-Generation Sequencing (NGS) Market: Regulatory Analysis
5.1. Introduction
5.2. North America
5.2.1. U.S.
5.2.2. Canada
5.3. Europe
5.4. Asia-Pacific
5.4.1. China
5.4.2. Japan
5.4.3. India
5.5. Latin America
5.6. Middle East

6. Next Generation Sequencing (NGS) Market Assessment?by Offering
6.1. Overview
6.2. Consumables
6.2.1. Sample Preparation Consumables
6.2.1.1. DNA Extraction and Amplification
6.2.1.2. Library Preparation & Target Enrichment
6.2.1.3. Quality Control
6.2.2. Other Consumables
6.3. NGS Platforms/Instruments
6.4. Software
6.5. Services

7. Global Next Generation Sequencing (NGS) Market Assessment–by Sequencing Type
7.1. Overview
7.2. Targeted Genome Sequencing
7.3. Whole Genome Sequencing
7.4. Whole Exome Sequencing
7.5. Other Sequencing Types

8. Global Next-Generation Sequencing (NGS) Market Assessment–by Technology
8.1. Overview
8.2. Sequencing by Synthesis
8.3. Ion Semiconductor Sequencing
8.4. Single-Molecule Real-Time Sequencing (SMRT)
8.5. Nanopore Sequencing
8.6. DNA Nanoball (DNB) Sequencing

9. Next-Generation Sequencing (NGS) Market Assessment–by Application
9.1. Overview
9.2. Research and Other Applications
9.2.1. Drug Discovery
9.2.2. Agriculture & Animal Research
9.2.3. Other Research Applications
9.3. Clinical Applications
9.3.1. Reproductive Health
9.3.2. Oncology
9.3.3. Infectious Diseases
9.3.4. Other Clinical Applications

10. Global Next-Generation Sequencing (NGS) Market Assessment–by End User
10.1. Overview
10.2. Pharmaceutical & Biotechnology Companies
10.3. Hospitals And Diagnostic Laboratories
10.4. Academic Institutes & Research Centers
10.5. Other End Users

11. Next-Generation Sequencing (NGS) Market Assessment?by Geography
11.1. Overview
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. France
11.3.3. U.K.
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Rest of Asia-Pacific (RoAPAC)
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of Latin America
11.6. Middle East & Africa

12. Competition Analysis
12.1. Overview
12.2. Key Growth Strategies
12.3. Competitive Benchmarking
12.4. Market Share Analysis (2022)
12.4.1. Illumina, Inc. (U.S.)
12.4.2. Thermo Fisher Scientific Inc. (U.S.)
12.4.3. Beijing Genomics Institute (BGI) (China)
12.5. Competitive Dashboard
12.5.1. Industry Leaders
12.5.2. Market Differentiators
12.5.3. Vanguards
12.5.4. Emerging Companies

13. Company Profiles (Business Overview, Financial Overview, Product Portfolio, SWOT Analysis of Top 5 Companies, and Strategic Developments)
13.1. Thermo Fisher Scientific, Inc.
13.2. Illumina, Inc.
13.3. Qiagen N.V.
13.4. F. Hoffmann-La Roche Ltd
13.5. Perkinelmer, Inc.
13.6. Agilent Technologies, Inc.
13.7. Pacific Biosciences of California, Inc.
13.8. Danaher Corporation
13.9. Bio-Rad Laboratories, Inc.
13.10. Oxford Nanopore Technologies Plc.
13.11. 10X Genomics, Inc.
13.12. Beijing Genomics Institute (BGI)
14. Appendix
14.1. Available Customization
14.2. Related Reports



List of Figures

List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global NGS Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 8 Global NGS Market, by Sequencing Type, 2023 Vs. 2030 (USD Million)
Figure 9 Global NGS Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 10 Global NGS Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 11 Global NGS Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Global NGS Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 13 Pharmaceutical R&D Expenditures in the U.S., Europe, and China, 2010 Vs. 2019 Vs. 2020 (USD Million)
Figure 14 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 15 Porter’s Five Forces Analysis
Figure 16 USFDA Regulatory Pathways for IVD Kits
Figure 17 EU Regulatory Pathway - IVDR 2017/746
Figure 18 China: Medical Device Classification and Pre-Market Requirements for NGS Instruments
Figure 19 Global NGS Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 20 Steps of Sample Preparation in a Typical NGS Workflow
Figure 21 Global NGS Market, by Sequencing Type, 2023 Vs. 2030 (USD Million)
Figure 22 Global NGS Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 23 Global NGS Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 24 U.S.: New Molecular Entity (NME) Approvals
Figure 25 Estimated Number of New Cancer Cases (in Million)
Figure 26 Global NGS Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 27 Global NGS Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 28 North America: NGS Market Snapshot
Figure 29 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 30 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 31 Europe: NGS Market Snapshot
Figure 32 Italy: Number of Biotechnology Firms, 2010-2021
Figure 33 Roe: Pharmaceutical R&D Expenditure, 2020
Figure 34 Asia-Pacific: NGS Market Snapshot
Figure 35 Latin America: NGS Market Snapshot
Figure 36 Key Growth Strategies Adopted by Leading Players, 2020– 2023
Figure 37 Next Generation Sequencing (NGS) Market: Competitive Benchmarking by Offering
Figure 38 Next Generation Sequencing (NGS) Market: Competitive Benchmarking, by Region
Figure 39 Global Next Generation Sequencing (NGS) Market Share Analysis, by Key Players, 2022 (%)
Figure 40 Competitive Dashboard: Next Generation Sequencing (NGS) Market
Figure 41 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 42 Illumina, Inc.: Financial Overview (2022)
Figure 43 Qiagen N.V.: Financial Overview (2022)
Figure 44 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
Figure 45 PerkinElmer, Inc.: Financial Overview (2022)
Figure 46 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 47 Pacific Biosciences of California, Inc.: Financial Overview (2022)
Figure 48 Danaher Corporation: Financial Overview (2022)
Figure 49 Bio-Rad Laboratories: Financial Overview (2022)
Figure 50 Oxford Nanopore Technologies Plc.: Financial Overview (2022)
Figure 51 10X Genomics, Inc.: Financial Overview (2022)
Figure 52 Beijing Genomics Institute (BGI): Financial Overview (2022)